GERD and NERD Treatment Companies

Latest Americas GERD & NERD Treatment Companies Updates:

AstraZeneca: Their proton pump inhibitor (PPI) Nexium continues to be a market leader, but faces patent expiry competition in some regions.

Eisai: Launched Zegerid OTC, an over-the-counter PPI, expanding their market reach.

Ironwood Pharmaceuticals: Their recently approved linaclotide, Linzess, continues to gain traction for chronic constipation and irritable bowel syndrome with constipation (IBS-C), which can overlap with NERD symptoms.

EndoGastric Solutions: Received FDA approval for the Stretta transoral, radiofrequency ablative device for GERD treatment, offering a minimally invasive option.Medtronic: Their RefluxStop device, which uses gastric electrical stimulation for GERD, is undergoing clinical trials and could potentially disrupt the market in the future.

List of Americas GERD & NERD Treatment Key companies in the market:

• AstraZeneca Plc (U.K)


• Boston Scientific Corporation (U.S.)


• Cempra Inc. (U.S.)


• Eisai Co., Ltd. (Japan)


• EndoGastric Solutions Inc. (U.S.)


• EndoStim Inc. (U.S.)


• GlaxoSmithKline Plc (U.K)


• Ironwood Pharmaceuticals, Inc. (U.S.)


• Jeil pharmaceutical Co. Ltd. (South Korea)


• Johnson & Johnson (U.S.)


• Mederi Therapeutics Inc. (U.S.)


• Medigus Ltd. (Israel)


• Medtronic Inc. (U.S.)


• Merck & CO., Inc. (U.S.)


• Novartis AG (Switzerland), Pfizer Inc. (U.S.)